COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
33542545
DOI
10.5507/bp.2021.011
Knihovny.cz E-zdroje
- Klíčová slova
- SARS-CoV-2, adrenal cortex, adrenal insufficiency, glucocorticoids, severe acute respiratory syndrome,
- MeSH
- adrenální insuficience komplikace farmakoterapie metabolismus MeSH
- COVID-19 komplikace terapie MeSH
- fyziologický stres MeSH
- glukokortikoidy terapeutické užití MeSH
- hormonální substituční terapie metody MeSH
- hospitalizace MeSH
- hydrokortison terapeutické užití MeSH
- lidé MeSH
- management nemoci MeSH
- nadledviny metabolismus MeSH
- progrese nemoci MeSH
- SARS-CoV-2 MeSH
- zánět MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- glukokortikoidy MeSH
- hydrokortison MeSH
The current Coronavirus disease outbreak requires that physicians work in collaboration with other physicians especially in intensive care and emergency units. To fight against this new disease, whose pathogenesis, effects, and results have not been clearly demonstrated, especially in patients with the pre-existing chronic disease, requires special expertise and perspectives. Due to the need for dynamic glucocorticoid treatment at different stages of the disease in patients with adrenal insufficiency, the existence of reports indicating that "coronavirus disease 2019" also affects the adrenal reserve, and the use of glucocorticoids also in advanced stages in patients with Coronavirus disease require this issue to be emphasized with precision. Herein, treatment of the pre-existing adrenal insufficiency in patients with actual Coronavirus disease and the effects of the this critical disease on the adrenal gland have been reviewed.
Citace poskytuje Crossref.org
Is there impact of the SARS-CoV-2 pandemic on steroidogenesis and fertility?
